The Latest Cardiac and Vascular News
DENVER, July 10, 2018 /PRNewswire/ — Medical device startup HeartHero announced today that it has raised a $1.5 million seed round investment from a venture capital firm, angel investors and grant funding. Initial investments will help HeartHero build a next-generation automated external defibrillator (AED). The company, which surpassed its initial funding goal, will focus now […]
TOKYO and PALO ALTO, Calif., July 10, 2018 /PRNewswire-USNewswire/ — Otsuka Holdings Co., Ltd. (“Otsuka Holdings”), Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) and ReCor Medical, Inc. (“ReCor”) announce the signing of a merger agreement pursuant to which Otsuka Holdings will acquire the remaining shares in ReCor from its current holders. The transaction is […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will release fourth-quarter results on July 30 after market close. In lieu of hosting a quarterly earnings conference call, CSI management will discuss fourth-quarter results at the beginning of its analyst day on July 31. The analyst day webcast will begin […]
REDWOOD CITY, Calif., July 09, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today provided operational updates for its fiscal 2018 first quarter which ended June 30, 2018. The Company’s premier product, Bioflux, has achieved market expansion […]
FRANKFURT, Germany, July 9, 2018 /PRNewswire/ — Prof. Dr. Achille Gaspardone, Director of Cardiology at Hospital of Sant’ Eugenio (Rome, Italy), and Prof. Dr. Horst Sievert MD, Director and Founder of Cardio Vascular Center (Frankfurt Germany), presented a LIVE PFO Closure to attendees of the Transcatheter Valve Therapies (TVT) Congress in Chicago, IL. The case was transmitted via […]
VANCOUVER, July 9, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that it will request a hearing before the Nasdaq Hearings Panel (the “Panel”) as the next step in the process to seeking an […]
MARLBOROUGH, Mass., July 5, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Cryterion Medical, Inc., a privately-held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). The addition of this cryoballoon platform positions the company as the first to have both cryothermal […]
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) today announced the first patient implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System after being included on the Australian Register of Therapeutic Goods last month in Australia. The first implants were performed by Professor Ian Spark […]
VANCOUVER, British Columbia, July 02, 2018 (GLOBE NEWSWIRE) — Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, wishes to provide the results of its recent Annual General Meeting. The Company is pleased to announce that all matters before the Board were approved at the […]
ANN ARBOR, Mich., July 03, 2018 (GLOBE NEWSWIRE) — Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C), today announced it will host an analyst and investor day in New […]
